SG Americas Securities’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $122K | Sell |
12,768
-417,283
| -97% | -$3.99M | ﹤0.01% | 2262 |
|
2025
Q1 | $4.5M | Buy |
430,051
+411,015
| +2,159% | +$4.3M | 0.01% | 457 |
|
2024
Q4 | $448K | Buy |
19,036
+692
| +4% | +$16.3K | ﹤0.01% | 1250 |
|
2024
Q3 | $659K | Buy |
18,344
+12,207
| +199% | +$439K | ﹤0.01% | 1270 |
|
2024
Q2 | $217K | Buy |
+6,137
| New | +$217K | ﹤0.01% | 1894 |
|
2024
Q1 | – | Sell |
-12,938
| Closed | -$172K | – | 2673 |
|
2023
Q4 | $172K | Buy |
+12,938
| New | +$172K | ﹤0.01% | 2094 |
|
2023
Q2 | – | Sell |
-11,183
| Closed | -$129K | – | 2171 |
|
2023
Q1 | $129K | Buy |
11,183
+1,380
| +14% | +$15.9K | ﹤0.01% | 2501 |
|
2022
Q4 | $114K | Sell |
9,803
-418
| -4% | -$4.86K | ﹤0.01% | 2391 |
|
2022
Q3 | $130K | Sell |
10,221
-530
| -5% | -$6.74K | ﹤0.01% | 2362 |
|
2022
Q2 | $74K | Buy |
+10,751
| New | +$74K | ﹤0.01% | 2915 |
|
2021
Q4 | – | Sell |
-71,317
| Closed | -$1.16M | – | 3060 |
|
2021
Q3 | $1.16M | Buy |
+71,317
| New | +$1.16M | 0.01% | 1623 |
|